Literature DB >> 6192341

Early pre-B cells from normal and X-linked agammaglobulinaemia produce C mu without an attached VH region.

J Schwaber, H Molgaard, S H Orkin, H J Gould, F S Rosen.   

Abstract

Differentiation of B lymphocytes follows an ordered pathway marked by somatic rearrangements of immunoglobulin heavy- and light-chain genes in conjunction with cellular transitions. Although low level constitutive transcription of the mu heavy-chain constant region (C mu) genes may occur in early precursor cells, activation of synthesis and translation of complete mu RNA is thought to accompany somatic rearrangements of DNA. Cytoplasmic mu-chain protein serves as a marker for pre-B cells, the earliest cells committed to differentiation into B lymphocytes, mu-chain gene expression in pre-B cells pre-cedes rearrangement and expression of light-chain genes. We now report that early human pre-B cells, Epstein--Barr virus transformed pre-B cells, and pre-B cell hybrid analogues, produce C mu without the normally associated heavy-chain variable (VH) region. Approximately 5% of normal pre-B cells from adult human bone marrow produce these incomplete mu-chains. Pre-B cells from three patients with X-linked agammaglobulinaemia are exclusively of this immature form, producing C mu without associated VH. This immune deficiency disease represents a block in differentiation secondary to failure to express VH genes.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6192341     DOI: 10.1038/304355a0

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  18 in total

1.  Evidence for failure of V(D)J recombination in bone marrow pre-B cells from X-linked agammaglobulinemia.

Authors:  J Schwaber
Journal:  J Clin Invest       Date:  1992-06       Impact factor: 14.808

2.  Germ line transcription of the immunoglobulin heavy chain locus directs production of mu chain without VDJ.

Authors:  J Schwaber; B Malone
Journal:  J Clin Invest       Date:  1992-06       Impact factor: 14.808

3.  Cell-type-specific synthesis of murine immunoglobulin mu RNA from an adenovirus vector.

Authors:  J E Ruether; A Maderious; D Lavery; J Logan; S M Fu; S Chen-Kiang
Journal:  Mol Cell Biol       Date:  1986-01       Impact factor: 4.272

Review 4.  Genetics of human X-linked immunodeficiency diseases.

Authors:  R W Hendriks; R K Schuurman
Journal:  Clin Exp Immunol       Date:  1991-08       Impact factor: 4.330

5.  Evidence for male X chromosomal mosaicism in X-linked agammaglobulinemia.

Authors:  R W Hendriks; E J Mensink; M E Kraakman; A Thompson; R K Schuurman
Journal:  Hum Genet       Date:  1989-10       Impact factor: 4.132

6.  Quantitation of mu mRNA by in situ hybridization reveals a correlation between B-maturation associated antigens and IgM gene activation in acute lymphatic leukemias.

Authors:  K Pachmann; B Dörken; B Emmerich; E Thiel
Journal:  Med Oncol Tumor Pharmacother       Date:  1988

7.  Variability in B cell maturation and differentiation in X-linked agammaglobulinemia.

Authors:  F E Leickley; R Buckley
Journal:  Clin Exp Immunol       Date:  1986-07       Impact factor: 4.330

8.  Premature termination of variable gene rearrangement in B lymphocytes from X-linked agammaglobulinemia.

Authors:  J Schwaber; R H Chen
Journal:  J Clin Invest       Date:  1988-06       Impact factor: 14.808

9.  Bone marrow cells in X-linked agammaglobulinemia express pre-B-specific genes (lambda-like and V pre-B) and present immunoglobulin V-D-J gene usage strongly biased to a fetal-like repertoire.

Authors:  M Milili; F Le Deist; G de Saint-Basile; A Fischer; M Fougereau; C Schiff
Journal:  J Clin Invest       Date:  1993-04       Impact factor: 14.808

10.  Correction of the molecular defect in B lymphocytes from X-linked agammaglobulinemia by cell fusion.

Authors:  J Schwaber; N Koenig; J Girard
Journal:  J Clin Invest       Date:  1988-10       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.